Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17057033 | METHOD AND KIT FOR PREDICTING THE OUTCOME OF AN ASSISTED REPRODUCTIVE TECHNOLOGY PROCEDURE | November 2020 | May 2024 | Abandon | 42 | 3 | 0 | No | No |
| 17094632 | MONITORING AND MANAGING A FACILITY MICROBIOME | November 2020 | November 2023 | Abandon | 36 | 0 | 1 | No | No |
| 17072890 | Compositions and Methods for Detecting or Quantifying Parainfluenza Virus | October 2020 | August 2024 | Allow | 46 | 3 | 0 | No | No |
| 17032310 | COMPOSITIONS AND METHODS FOR DETECTING ZIKA VIRUS NUCLEIC ACID | September 2020 | August 2023 | Allow | 34 | 1 | 0 | No | No |
| 17041874 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CANCER | September 2020 | February 2024 | Abandon | 41 | 1 | 0 | No | No |
| 16978027 | HIGH THROUGHPUT NUCLEIC ACID PROFILING OF SINGLE CELLS | September 2020 | July 2023 | Allow | 34 | 1 | 1 | No | No |
| 17010539 | SINGLE NUCLEOTIDE POLYMORPHISM MARKER RELATED TO CHINESE HORSE SHORT STATURE TRAIT AND USE THEREOF | September 2020 | November 2022 | Allow | 26 | 1 | 0 | No | No |
| 17006363 | SELF-METERING OF FLUID INTO A REACTION CHAMBER | August 2020 | May 2024 | Allow | 44 | 2 | 0 | Yes | No |
| 16984878 | Molecular Marker For Identifying Sanxan Gum and Its Synthetic Strain, Preparation Method And Application Thereof | August 2020 | June 2022 | Abandon | 22 | 2 | 0 | No | No |
| 16967319 | METHODS FOR DETECTING FUNGI IN TURF GRASS WITH A LAMP ASSAY HAVING NOVEL PRIMER SETS | August 2020 | December 2022 | Allow | 28 | 1 | 1 | No | No |
| 16963144 | METHOD FOR QUANTITATIVELY DETECTING VBNC STATE BACTERIA | July 2020 | May 2022 | Abandon | 22 | 1 | 0 | No | No |
| 16927472 | SOYBEAN EVENT DP-305423-1 AND COMPOSITIONS AND METHODS FOR THE IDENTIFICATION AND/OR DETECTION THEREOF | July 2020 | March 2022 | Allow | 20 | 1 | 0 | No | No |
| 16907237 | Method, system and device for automated NGS library preparation | June 2020 | April 2024 | Abandon | 46 | 1 | 1 | No | No |
| 16764765 | METHODS FOR DETECTION OF ANTIBIOTIC RESISTANT H. PYLORI | May 2020 | March 2023 | Allow | 34 | 1 | 0 | No | No |
| 16875381 | Method for Detecting multiple DNA Mutations and Copy Number Variations | May 2020 | April 2024 | Abandon | 47 | 2 | 1 | No | No |
| 16759577 | Targeted cell free nucleic acid analysis | April 2020 | April 2023 | Allow | 35 | 1 | 1 | No | No |
| 16856036 | NOVEL COMPOSITIONS, METHODS AND KITS FOR MICROORGANISM DETECTION | April 2020 | March 2024 | Allow | 47 | 3 | 1 | No | No |
| 16855217 | COMPOSITIONS AND METHODS FOR DETECTING A BIOLOGICAL CONTAMINANT | April 2020 | October 2022 | Allow | 30 | 1 | 1 | No | No |
| 16846188 | METHOD FOR CONFIRMING THE PRESENCE OF AN ANALYTE | April 2020 | July 2022 | Abandon | 27 | 1 | 0 | No | No |
| 16755004 | mecA GENE AMPLIFICATION PRIMER PAIR, mecA GENE DETECTION KIT AND mecA GENE DETECTION METHOD | April 2020 | March 2023 | Abandon | 35 | 2 | 1 | Yes | No |
| 16796832 | METHODS OF SCREENING FOR CAUSATIVE AGENTS OF ONYCHODYSTROPHY | February 2020 | October 2022 | Allow | 32 | 1 | 1 | Yes | No |
| 16639324 | METHOD FOR DETECTING OFF-TYPE OF BRASSICA OLERACEA PLANT | February 2020 | November 2023 | Allow | 45 | 3 | 1 | Yes | No |
| 16789866 | HEATING MECHANISM FOR DNA AMPLIFICATION, EXTRACTION OR STERILIZATION USING PHOTO-THERMAL NANOPARTICLES | February 2020 | June 2023 | Allow | 40 | 3 | 0 | No | No |
| 16789276 | Real Time Cleavage Assay | February 2020 | July 2022 | Allow | 29 | 1 | 0 | No | No |
| 16773336 | TARGET ENRICHMENT BY SINGLE PROBE PRIMER EXTENSION | January 2020 | April 2022 | Allow | 27 | 0 | 1 | No | No |
| 16633912 | METHODS FOR DETERMINING WHETHER A PATIENT SUFFERING FROM RHABDOMYOLYSIS ACHIEVES A RESPONSE WITH A TLR9 ANTAGONIST | January 2020 | June 2022 | Allow | 29 | 0 | 1 | No | No |
| 16630521 | PREDICTIVE TEST OF ANTI-TNF ALPHA RESPONSE IN PATIENTS WITH AN INFLAMMATORY DISEASE | January 2020 | February 2023 | Abandon | 37 | 1 | 1 | No | No |
| 16624791 | PCR PRIMER PAIR AND APPLICATION THEREOF | December 2019 | July 2023 | Allow | 43 | 2 | 1 | Yes | No |
| 16711194 | METHODS FOR DIAGNOSING AND MONITORING TREATMENT OF BACTERIAL VAGINOSIS | December 2019 | December 2021 | Allow | 25 | 1 | 0 | No | No |
| 16692837 | COMPOSITIONS AND METHODS FOR IDENTIFYING DRUG RESISTANT TUBERCULOSIS | November 2019 | September 2021 | Allow | 22 | 0 | 0 | No | No |
| 16614125 | Diagnostic Assays for Detecting, Quantifying, and/or Tracking Microbes and Other Analytes | November 2019 | October 2022 | Abandon | 36 | 1 | 1 | No | No |
| 16612398 | METHOD FOR DETECTING C. PERFRINGENS INDUCED DISEASES IN ANIMALS | November 2019 | December 2022 | Allow | 37 | 3 | 1 | Yes | No |
| 16610476 | TUMOR VS. MATCHED NORMAL cfRNA | November 2019 | September 2021 | Abandon | 23 | 1 | 1 | No | No |
| 16672224 | Compositions and Methods for Detecting or Quantifying Hepatitis B Virus | November 2019 | August 2021 | Allow | 22 | 2 | 0 | No | No |
| 16659375 | COMPOSITIONS AND METHODS FOR DETECTING ZIKA VIRUS NUCLEIC ACID | October 2019 | March 2022 | Allow | 29 | 3 | 1 | No | No |
| 16599543 | GLUCANASE PRODUCTION AND METHODS OF USING THE SAME | October 2019 | April 2021 | Allow | 18 | 0 | 1 | Yes | No |
| 16499515 | METHODS AND DEVICES FOR IDENTIFYING MICROBIAL INFECTIONS | September 2019 | June 2023 | Allow | 45 | 3 | 1 | No | No |
| 16495744 | Methods For Multiplex Detection Of Molecules | September 2019 | July 2024 | Abandon | 58 | 2 | 1 | No | No |
| 16488258 | METHOD FOR DIAGNOSING CHRONIC OBSTRUCTIVE AIRWAY DISEASE THROUGH BACTERIAL METAGENOME ANALYSIS | August 2019 | April 2023 | Abandon | 44 | 2 | 1 | No | No |
| 16488263 | METHOD FOR DIAGNOSING PARKINSON'S DISEASE THROUGH BACTERIAL METAGENOME ANALYSIS | August 2019 | December 2023 | Abandon | 51 | 4 | 1 | No | No |
| 16469634 | AMPLIFICATION-INTEGRATED GENETIC MATERIAL DEPLETION OF NON-TARGET ORGANISMS USING DIFFERENTIALLY ABUNDANT K-MERS | June 2019 | September 2022 | Allow | 40 | 1 | 1 | No | No |
| 16462859 | Yeast Cell Extract Assisted Construction of DNA Molecules | May 2019 | May 2023 | Abandon | 48 | 1 | 0 | No | No |
| 16417071 | NICKING AND EXTENSION AMPLIFICATION REACTION (NEAR) OF STREPTOCOCCUS SPECIES | May 2019 | July 2021 | Allow | 26 | 2 | 0 | No | No |
| 16399305 | METHODS AND COMPOSITIONS FOR DIRECT CHEMICAL LYSIS | April 2019 | June 2022 | Allow | 38 | 2 | 1 | No | No |
| 16390680 | METHODS AND SYSTEMS FOR SEQUENCING NUCLEIC ACIDS | April 2019 | December 2021 | Abandon | 32 | 1 | 0 | No | No |
| 16340451 | NUCLEIC ACID ENCODING SM1 RESISTANCE TO ORANGE WHEAT BLOSSOM MIDGE AND METHOD OF USE | April 2019 | September 2023 | Allow | 53 | 2 | 1 | Yes | No |
| 16373507 | PROXIMITY ASSAYS FOR DETECTING NUCLEIC ACIDS AND PROTEINS IN A SINGLE CELL | April 2019 | May 2021 | Abandon | 25 | 1 | 0 | No | No |
| 16283232 | METHODS AND KITS TO IDENTIFY KLEBSIELLA STRAINS | February 2019 | May 2021 | Allow | 26 | 1 | 0 | No | No |
| 16246608 | MAIZE EVENT DP-004114-3 AND METHODS FOR DETECTION THEREOF | January 2019 | February 2021 | Allow | 25 | 1 | 0 | No | No |
| 16243829 | Nicking and Extension Amplification Reaction for the Exponential Amplification of Nucleic Acids | January 2019 | May 2022 | Abandon | 40 | 2 | 0 | No | No |
| 16242962 | COMPOSITIONS AND METHODS FOR SAMPLE PROCESSING | January 2019 | December 2020 | Abandon | 24 | 2 | 1 | Yes | No |
| 16233880 | SINGLE SPIN PROCESS FOR BLOOD PLASMA SEPARATION AND PLASMA COMPOSITION INCLUDING PRESERVATIVE | December 2018 | January 2021 | Allow | 32 | 3 | 0 | Yes | No |
| 16311450 | Method to Screen For a Mutant Within a Population of Organisms By Applying a Pooling and Splitting Approach | December 2018 | September 2023 | Allow | 57 | 3 | 1 | Yes | No |
| 16221944 | METHODS OF DETECTING DDR2 MUTATIONS | December 2018 | May 2021 | Allow | 29 | 1 | 1 | No | No |
| 16216307 | RAD51C as a Human Cancer Susceptibility Gene | December 2018 | April 2021 | Abandon | 28 | 0 | 1 | No | No |
| 16212539 | COMPOSITIONS AND METHODS FOR AMPLIFYING AND CHARACTERIZING HCV NUCLEIC ACID | December 2018 | May 2021 | Allow | 29 | 1 | 1 | Yes | No |
| 16209855 | HIV-1 GENOTYPING AND CORECEPTOR TROPISM ASSAY | December 2018 | January 2022 | Abandon | 38 | 2 | 0 | No | No |
| 16209111 | ASSAYS AND METHODS RELATING TO THE TREATMENT OF MELANOMA | December 2018 | February 2020 | Allow | 15 | 1 | 0 | Yes | No |
| 16198902 | METHODS OF ENRICHING AND DETERMINING TARGET NUCLEOTIDE SEQUENCES | November 2018 | February 2022 | Allow | 38 | 3 | 1 | No | No |
| 16097404 | MULTIPLEXED OPTIMIZED MISMATCH AMPLIFICATION (MOMA)-REAL TIME PCR FOR ASSESSING CANCER | October 2018 | September 2022 | Abandon | 47 | 2 | 1 | No | No |
| 16097422 | MULTIPLEXED OPTIMIZED MISMATCH AMPLIFICATION (MOMA)-REAL TIME PCR FOR ASSESSING FETAL WELL BEING | October 2018 | September 2022 | Abandon | 47 | 2 | 1 | No | No |
| 16167737 | COMPOSITIONS FOR DETECTING BV-ASSOCIATED BACTERIAL NUCLEIC ACID | October 2018 | April 2020 | Allow | 18 | 3 | 0 | No | No |
| 15744149 | METHODS, COMPOSITIONS, KITS, AND USES FOR ANALYSIS OF NUCLEIC ACIDS COMPRISING REPEATING A/T-RICH SEGMENTS | September 2018 | August 2021 | Allow | 43 | 1 | 1 | No | No |
| 16081269 | METHODS FOR CHARACTERIZING THE CELLULAR REPAIR RESPONSE AFTER SOFT TISSUE INJURY | August 2018 | May 2023 | Abandon | 56 | 3 | 1 | No | No |
| 16079360 | POLYMERASE CHAIN REACTION PATCH, METHOD AND DEVICE FOR DIAGNOSIS USING THE SAME | August 2018 | June 2023 | Allow | 58 | 3 | 1 | No | No |
| 16105480 | SYSTEMS AND METHODS FOR HIGH EFFICIENCY ELECTRONIC SEQUENCING AND DETECTION | August 2018 | November 2021 | Allow | 39 | 1 | 1 | Yes | No |
| 16104504 | HEATING MECHANISM FOR DNA AMPLIFICATION, EXTRACTION OR STERILIZATION USING PHOTO-THERMAL NANOPARTICLES | August 2018 | November 2019 | Allow | 15 | 1 | 0 | No | No |
| 15999245 | MOLECULAR PROGRAMMING TOOLS | August 2018 | November 2021 | Allow | 39 | 1 | 1 | No | No |
| 16056231 | COMPOSITIONS AND METHODS FOR SAMPLE PROCESSING | August 2018 | September 2022 | Allow | 50 | 6 | 1 | Yes | No |
| 16042577 | METHOD FOR HIGH-THROUGHPUT SCREENING OF TRANSGENIC PLANTS | July 2018 | February 2021 | Allow | 31 | 1 | 0 | No | No |
| 16017570 | COMPOSITIONS OF TOEHOLD PRIMER DUPLEXES AND METHODS OF USE | June 2018 | March 2021 | Abandon | 33 | 1 | 0 | No | No |
| 16015407 | SALIVA COLLECTION, PROCESSING, STABILIZATION, AND STORAGE METHOD | June 2018 | February 2021 | Abandon | 32 | 0 | 1 | No | No |
| 15989814 | Customizable Sample Processing Device | May 2018 | November 2022 | Allow | 54 | 3 | 1 | No | No |
| 15775780 | METHOD OF TRANSLOCATING NUCLEIC ACIDS THROUGH NANOPORES | May 2018 | August 2021 | Abandon | 39 | 1 | 1 | No | No |
| 15950921 | OLIGONUCLEOTIDES AND METHODS FOR THE PREPARATION OF RNA LIBRARIES | April 2018 | July 2021 | Allow | 39 | 2 | 0 | No | No |
| 15941685 | PRIMER COMPOSITIONS AND MULTIPLEX METHODS FOR DETECTING THE PRESENCE OF LISTERIA | March 2018 | July 2020 | Abandon | 28 | 1 | 1 | No | No |
| 15940274 | FULL COLD-PCR ENRICHMENT WITH REFERENCE BLOCKING SEQUENCE | March 2018 | July 2021 | Allow | 39 | 1 | 1 | No | No |
| 15934273 | COMPOSITIONS AND METHODS FOR DETECTING OR QUANTIFYING PARAINFLUENZA VIRUS | March 2018 | July 2020 | Allow | 28 | 1 | 1 | Yes | No |
| 15577242 | DOUBLE-FUNCTIONAL OLIGONUCLEOTIDE COMPRISING COMPLEMENTARY NUCLEOTIDE SEQUENCE, MIS-MATCHED NUCLEOTIDE SEQUENCE, REPORTER, AND QUENCHER, AND A METHODS FOR NUCLEIC ACID AMPLIFICATION AND MEASUREMENT USING THE SAME | March 2018 | September 2021 | Abandon | 46 | 2 | 1 | Yes | No |
| 15899227 | PCR AMPLIFICATION METHODS FOR DETECTING AND QUANTIFYING SULFATE-REDUCING BACTERIA IN OILFIELD FLUIDS | February 2018 | July 2019 | Allow | 17 | 2 | 0 | No | No |
| 15750345 | METHOD FOR GENERATING A RNA-SEQUENCING LIBRARY | February 2018 | October 2021 | Allow | 44 | 3 | 1 | No | No |
| 15876347 | Multiplexed Signal Amplified FISH via Splinted Ligation Amplification and Sequencing | January 2018 | January 2021 | Allow | 35 | 2 | 0 | Yes | No |
| 15873667 | Methods and Compositions for Enrichment of Target Polynucleotides | January 2018 | December 2020 | Allow | 34 | 1 | 1 | No | No |
| 15742237 | ENZYMATIC SYNTHESIS OF NUCLEIC ACID SEQUENCES | January 2018 | April 2021 | Abandon | 39 | 2 | 0 | No | No |
| 15739587 | ORTHOGONAL DEBLOCKING OF NUCLEOTIDES | December 2017 | January 2021 | Allow | 37 | 1 | 1 | No | No |
| 15847816 | GENETIC TEST FOR DETECTING CONGENITAL ADRENAL HYPERPLASIA | December 2017 | September 2020 | Allow | 33 | 2 | 0 | No | No |
| 15839597 | METHODS FOR ASSEMBLING DNA MOLECULES | December 2017 | February 2021 | Allow | 39 | 2 | 1 | No | No |
| 15735273 | RAPID CONCENTRATION, RECOVERY AND DETECTION OF PATHOGENS IN FOOD SAMPLES | December 2017 | May 2023 | Allow | 60 | 6 | 1 | No | No |
| 15834555 | COMPOSITIONS AND METHODS FOR DETECTION AND DISCRIMINATION OF EMERGING INFLUENZA VIRUS SUBTYPES | December 2017 | January 2019 | Allow | 14 | 2 | 1 | Yes | No |
| 15517449 | Oligonucleotides, Oligonucleotide Set, Kit For Diagnosis And Discrimination Of HTLV-1/2 Infection, Polynucleotyde Suitable For Use As A Reference Target For Primer And Probe Design For Detection And Differentiation of HTLV-1 and HTLV-2, Amplicon, And Method For Detecting At Least One HTLV Target | December 2017 | July 2020 | Abandon | 40 | 1 | 1 | No | No |
| 15576923 | KIT FOR TOGETHER DETECTING MULTIPLE TARGET NUCLEIC ACIDS DIFFERING FROM EACH OTHER AND DETECTION METHOD USING THE SAME | November 2017 | July 2021 | Abandon | 44 | 2 | 1 | No | No |
| 15816036 | COMPOSITIONS AND METHODS FOR DETECTING OR QUANTIFYING HEPATITIS B VIRUS | November 2017 | July 2019 | Allow | 20 | 2 | 1 | No | No |
| 15803975 | METHOD FOR USING PROBE BASED PCR DETECTION TO MEASURE THE LEVELS OF CIRCULATING DEMETHYLATED BETA CELL DERIVED DNA AS A MEASURE OF BETA CELL LOSS IN DIABETES | November 2017 | November 2018 | Allow | 12 | 1 | 0 | Yes | No |
| 15572023 | Detection of Target Nucleic Acid Variants | November 2017 | May 2021 | Allow | 42 | 2 | 1 | Yes | No |
| 15802408 | METHODS OF NUCLEIC ACID SAMPLE PREPARATION FOR IMMUNE REPERTOIRE SEQUENCING | November 2017 | November 2020 | Allow | 36 | 1 | 1 | No | No |
| 15570947 | AUTOMATABLE METHOD FOR NUCLEIC ACID ISOLATION | October 2017 | July 2020 | Allow | 32 | 1 | 1 | Yes | No |
| 15799241 | Enhancing Sequencing Performance in Sequencing-by-Synthesis | October 2017 | June 2019 | Abandon | 20 | 0 | 1 | No | No |
| 15567612 | A primer combination and GeXP detection method for simultaneously identifying eight kinds of bovine pathogens | October 2017 | October 2019 | Abandon | 24 | 2 | 1 | No | No |
| 15786627 | SOYBEAN EVENT DP-305423-1 AND COMPOSITIONS AND METHODS FOR THE IDENTIFICATION AND/OR DETECTION THEREOF | October 2017 | April 2020 | Allow | 30 | 1 | 1 | No | No |
| 15566600 | PORTABLE NUCLEIC ACID EXTRACTION APPARATUS AND METHOD OF USING THE SAME | October 2017 | January 2023 | Allow | 60 | 5 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner OYEYEMI, OLAYINKA A.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 20.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner OYEYEMI, OLAYINKA A works in Art Unit 1637 and has examined 363 patent applications in our dataset. With an allowance rate of 54.5%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 37 months.
Examiner OYEYEMI, OLAYINKA A's allowance rate of 54.5% places them in the 17% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by OYEYEMI, OLAYINKA A receive 2.34 office actions before reaching final disposition. This places the examiner in the 62% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by OYEYEMI, OLAYINKA A is 37 months. This places the examiner in the 31% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +51.5% benefit to allowance rate for applications examined by OYEYEMI, OLAYINKA A. This interview benefit is in the 93% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 24.1% of applications are subsequently allowed. This success rate is in the 38% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 38.4% of cases where such amendments are filed. This entry rate is in the 59% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 1% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 73.3% of appeals filed. This is in the 62% percentile among all examiners. Of these withdrawals, 72.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 72.6% are granted (fully or in part). This grant rate is in the 78% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.3% of allowed cases (in the 53% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.0% of allowed cases (in the 70% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.